MEDICINOVA, INC. Research and Development Expense
MEDICINOVA, INC. (MNOV) reported Research and Development Expense of $900.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- MEDICINOVA, INC. research and development expense for the quarter ending 2026-06-30 was $900.00K, a 55.00% decline year-over-year.
- MEDICINOVA, INC. research and development expense for the quarter ending 2026-03-31 was $1.20M, a 29.41% decline year-over-year.
- MEDICINOVA, INC. research and development expense for the quarter ending 2025-12-31 was $1.40M, a 22.22% decline year-over-year.
- MEDICINOVA, INC. research and development expense for the quarter ending 2025-09-30 was $1.50M, a 16.67% decline year-over-year.
- MEDICINOVA, INC. research and development expense for fiscal 2025 was $6.70M, a 1.47% decline from fiscal 2024.
- MEDICINOVA, INC. research and development expense for fiscal 2024 was $6.80M, a 28.30% increase from fiscal 2023.
- MEDICINOVA, INC. research and development expense for fiscal 2023 was $5.30M, a 39.08% decline from fiscal 2022.
- MEDICINOVA, INC. research and development expense for fiscal 2022 was $8.70M, a 7.41% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 129 month | Research and Development Expense 132 month | Research and Development Expense 135 month | Research and Development Expense 138 month | Research and Development Expense 141 month | Research and Development Expense 144 month | Research and Development Expense 147 month | Research and Development Expense 150 month | Research and Development Expense 153 month | Research and Development Expense 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $900.00K 10-Q · filed 2026-08-13 | $2.10M 10-Q · filed 2026-08-13 | $3.50M derived: sum of 3 quarters · filed 2026-08-13 | $5.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-14 | $2.60M derived: sum of 2 quarters · filed 2026-05-14 | $4.10M derived: sum of 3 quarters · filed 2026-05-14 | $6.10M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $2.90M derived: sum of 2 quarters · filed 2026-03-10 | $4.90M derived: sum of 3 quarters · filed 2026-08-13 | $6.70M 10-K · filed 2026-03-10 | ||||||||||||||
| 2025-09-30 | $1.50M 10-Q · filed 2025-11-12 | $3.50M derived: sum of 2 quarters · filed 2026-08-13 | $5.30M 10-Q · filed 2025-11-12 | $7.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-06-30 | $2.00M 10-Q · filed 2026-08-13 | $3.70M 10-Q · filed 2026-08-13 | $5.50M derived: sum of 3 quarters · filed 2026-08-13 | $7.30M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||
| 2025-03-31 | $1.70M 10-Q · filed 2026-05-14 | $3.50M derived: sum of 2 quarters · filed 2026-05-14 | $5.30M derived: sum of 3 quarters · filed 2026-05-14 | $6.80M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||
| 2024-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $3.60M derived: sum of 2 quarters · filed 2026-03-10 | $5.10M derived: sum of 3 quarters · filed 2026-03-10 | $6.80M 10-K · filed 2026-03-10 | ||||||||||||||
| 2024-09-30 | $1.80M 10-Q · filed 2025-11-12 | $3.30M derived: sum of 2 quarters · filed 2025-11-12 | $5.00M 10-Q · filed 2025-11-12 | $6.60M derived: sum of 4 quarters · filed 2025-11-12 | ||||||||||||||
| 2024-06-30 | $1.50M 10-Q · filed 2025-08-14 | $3.20M 10-Q · filed 2025-08-14 | $4.80M derived: sum of 3 quarters · filed 2025-08-14 | $5.50M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-13 | $3.30M derived: sum of 2 quarters · filed 2025-05-13 | $4.00M derived: sum of 3 quarters · filed 2025-05-13 | $5.60M derived: sum of 4 quarters · filed 2025-05-13 | ||||||||||||||
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $2.30M derived: sum of 2 quarters · filed 2025-02-19 | $3.90M derived: sum of 3 quarters · filed 2025-02-19 | $5.30M 10-K · filed 2025-02-19 | ||||||||||||||
| 2023-09-30 | $700.00K 10-Q · filed 2024-11-13 | $2.30M derived: sum of 2 quarters · filed 2024-11-13 | $3.70M 10-Q · filed 2024-11-13 | $5.60M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||||||||
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-08 | $3.00M 10-Q · filed 2024-08-08 | $4.90M derived: sum of 3 quarters · filed 2024-08-08 | $7.30M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||||||
| 2023-03-31 | $1.40M 10-Q · filed 2024-05-09 | $3.30M derived: sum of 2 quarters · filed 2024-05-09 | $5.70M derived: sum of 3 quarters · filed 2024-05-09 | $8.20M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||||||
| 2022-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $4.30M derived: sum of 2 quarters · filed 2024-02-15 | $6.80M derived: sum of 3 quarters · filed 2024-02-15 | $8.70M 10-K · filed 2024-02-15 | ||||||||||||||
| 2022-09-30 | $2.40M 10-Q · filed 2023-11-09 | $4.90M derived: sum of 2 quarters · filed 2023-11-09 | $6.80M 10-Q · filed 2023-11-09 | $8.60M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | $2.50M 10-Q · filed 2023-08-09 | $4.50M 10-Q · filed 2023-08-09 | $6.20M derived: sum of 3 quarters · filed 2023-08-09 | $8.20M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||||||
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-11 | $3.70M derived: sum of 2 quarters · filed 2023-05-11 | $5.70M derived: sum of 3 quarters · filed 2023-05-11 | $8.00M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||||||||
| 2021-12-31 | $1.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | $3.70M derived: sum of 2 quarters · filed 2023-03-28 | $6.00M derived: sum of 3 quarters · filed 2023-03-28 | $8.10M 10-K/A · filed 2023-03-28 | ||||||||||||||
| 2021-09-30 | $2.00M 10-Q · filed 2022-11-10 | $4.30M derived: sum of 2 quarters · filed 2022-11-10 | $6.40M 10-Q · filed 2022-11-10 | $8.00M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||||
| 2021-06-30 | $2.30M 10-Q · filed 2022-08-11 | $4.40M 10-Q · filed 2022-08-11 | $6.00M derived: sum of 3 quarters · filed 2022-08-11 | $8.10M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||||
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-12 | $3.70M derived: sum of 2 quarters · filed 2022-05-12 | $5.80M derived: sum of 3 quarters · filed 2022-05-12 | $7.90M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $3.80M derived: sum of 2 quarters · filed 2022-02-16 | $5.90M derived: sum of 3 quarters · filed 2022-02-16 | $7.10M 10-K · filed 2022-02-16 | ||||||||||||||
| 2020-09-30 | $2.10M 10-Q · filed 2021-11-12 | $4.20M derived: sum of 2 quarters · filed 2021-11-12 | $5.40M 10-Q · filed 2021-11-12 | $7.10M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||||||
| 2020-06-30 | $2.10M 10-Q · filed 2021-08-12 | $3.30M 10-Q · filed 2021-08-12 | $5.00M derived: sum of 3 quarters · filed 2021-08-12 | $6.10M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-13 | $2.90M derived: sum of 2 quarters · filed 2021-05-13 | $4.00M derived: sum of 3 quarters · filed 2021-05-13 | $5.40M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||
| 2019-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $2.80M derived: sum of 2 quarters · filed 2021-02-19 | $4.20M derived: sum of 3 quarters · filed 2021-02-19 | $5.70M 10-K · filed 2021-02-19 | ||||||||||||||
| 2019-09-30 | $1.10M 10-Q · filed 2020-10-26 | $2.50M derived: sum of 2 quarters · filed 2020-10-26 | $4.00M 10-Q · filed 2020-10-26 | $4.10M derived: sum of 4 quarters · filed 2020-10-26 | ||||||||||||||
| 2019-06-30 | $1.40M 10-Q · filed 2020-07-28 | $2.90M 10-Q · filed 2020-07-28 | $3.00M derived: sum of 3 quarters · filed 2020-07-28 | $5.30M derived: sum of 4 quarters · filed 2020-07-28 | ||||||||||||||
| 2019-03-31 | $1.50M 10-Q · filed 2020-04-23 | $1.60M derived: sum of 2 quarters · filed 2020-04-23 | $3.90M derived: sum of 3 quarters · filed 2020-04-23 | $5.20M derived: sum of 4 quarters · filed 2020-04-23 | ||||||||||||||
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $2.40M derived: sum of 2 quarters · filed 2020-02-13 | $3.70M derived: sum of 3 quarters · filed 2020-02-13 | $5.30M 10-K · filed 2020-02-13 | ||||||||||||||
| 2018-09-30 | $2.30M 10-Q · filed 2019-10-24 | $3.60M derived: sum of 2 quarters · filed 2019-10-24 | $5.20M 10-Q · filed 2019-10-24 | $6.20M derived: sum of 4 quarters · filed 2019-10-24 | ||||||||||||||
| 2018-06-30 | $1.30M 10-Q · filed 2019-07-25 | $2.90M 10-Q · filed 2019-07-25 | $3.90M derived: sum of 3 quarters · filed 2019-07-25 | $5.10M derived: sum of 4 quarters · filed 2019-07-25 | ||||||||||||||
| 2018-03-31 | $1.60M 10-Q · filed 2019-04-25 | $2.60M derived: sum of 2 quarters · filed 2019-04-25 | $3.80M derived: sum of 3 quarters · filed 2019-04-25 | $4.60M derived: sum of 4 quarters · filed 2019-04-25 | ||||||||||||||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $2.20M derived: sum of 2 quarters · filed 2019-02-13 | $3.00M derived: sum of 3 quarters · filed 2019-02-13 | $3.90M 10-K · filed 2019-02-13 | ||||||||||||||
| 2017-09-30 | $1.20M 10-Q · filed 2018-10-25 | $2.00M derived: sum of 2 quarters · filed 2018-10-25 | $2.90M 10-Q · filed 2018-10-25 | $3.20M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||||||
| 2017-06-30 | $800.00K 10-Q · filed 2018-07-23 | $1.70M 10-Q · filed 2018-07-23 | $2.00M derived: sum of 3 quarters · filed 2019-02-13 | $2.80M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||||||
| 2017-03-31 | $800.00K 10-Q · filed 2018-04-25 | $1.20M derived: sum of 2 quarters · filed 2019-02-13 | $2.00M derived: sum of 3 quarters · filed 2019-02-13 | $2.90M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||||||
| 2016-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $1.20M derived: sum of 2 quarters · filed 2019-02-13 | $2.10M derived: sum of 3 quarters · filed 2019-02-13 | $3.10M 10-K · filed 2019-02-13 | ||||||||||||||
| 2016-09-30 | $800.00K 10-Q · filed 2017-10-23 | $1.70M derived: sum of 2 quarters · filed 2017-10-23 | $2.70M 10-Q · filed 2017-10-23 | $3.50M derived: sum of 4 quarters · filed 2018-02-13 | ||||||||||||||
| 2016-06-30 | $900.00K 10-Q · filed 2017-07-26 | $1.80M 10-Q · filed 2017-07-26 | $2.70M derived: sum of 3 quarters · filed 2018-02-13 | $3.20M derived: sum of 4 quarters · filed 2018-02-13 | ||||||||||||||
| 2016-03-31 | $1.00M 10-Q · filed 2017-04-26 | $1.80M derived: sum of 2 quarters · filed 2018-02-13 | $2.30M derived: sum of 3 quarters · filed 2018-02-13 | $3.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||||||||||||
| 2015-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $1.30M derived: sum of 2 quarters · filed 2018-02-13 | $2.00M derived: sum of 3 quarters · filed 2018-02-13 | $2.70M 10-K · filed 2018-02-13 | ||||||||||||||
| 2015-09-30 | $500.00K 10-Q · filed 2016-10-25 | $1.20M derived: sum of 2 quarters · filed 2016-10-25 | $1.90M 10-Q · filed 2016-10-25 | $2.50M derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||||||
| 2015-06-30 | $700.00K 10-Q · filed 2016-07-26 | $1.30M 10-Q · filed 2016-07-26 | $2.00M derived: sum of 3 quarters · filed 2017-02-14 | $2.80M derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||||||
| 2015-03-31 | $600.00K 10-Q · filed 2016-04-27 | $1.30M derived: sum of 2 quarters · filed 2017-02-14 | $2.10M derived: sum of 3 quarters · filed 2017-02-14 | $2.80M derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||||||
| 2014-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.50M derived: sum of 2 quarters · filed 2017-02-14 | $2.20M derived: sum of 3 quarters · filed 2017-02-14 | $2.90M 10-K · filed 2017-02-14 | ||||||||||||||
| 2014-09-30 | $800.00K 10-Q · filed 2015-10-29 | $1.50M derived: sum of 2 quarters · filed 2015-10-29 | $2.20M 10-Q · filed 2015-10-29 | $2.80M derived: sum of 4 quarters · filed 2015-10-29 | ||||||||||||||
| 2014-06-30 | $700.00K 10-Q · filed 2015-07-30 | $1.40M 10-Q · filed 2015-07-30 | $2.00M derived: sum of 3 quarters · filed 2015-07-30 | $2.60M derived: sum of 4 quarters · filed 2015-07-30 | ||||||||||||||
| 2014-03-31 | $600.00K 10-Q · filed 2015-05-11 | $1.30M derived: sum of 2 quarters · filed 2015-05-11 | $1.90M derived: sum of 3 quarters · filed 2015-05-11 | $2.70M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||||||||
| 2013-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.30M derived: sum of 2 quarters · filed 2015-03-12 | $2.10M derived: sum of 3 quarters · filed 2015-03-12 | $2.70M 10-K · filed 2015-03-12 | ||||||||||||||
| 2013-09-30 | $600.00K 10-Q · filed 2014-11-13 | $785.57K 10-Q · filed 2013-11-07 | $1.40M derived: sum of 2 quarters · filed 2014-11-13 | $2.00M 10-Q · filed 2014-11-13 | $2.43M 10-Q · filed 2013-11-07 | $2.17M derived: sum of 4 quarters · filed 2014-11-13 | $169.48M 10-Q · filed 2013-11-07 | |||||||||||
| 2013-06-30 | $800.00K 10-Q · filed 2014-08-13 | $946.11K 10-Q · filed 2013-08-08 | $1.30M 10-Q · filed 2014-08-13 | $1.64M 10-Q · filed 2013-08-08 | $1.57M derived: sum of 3 quarters · filed 2014-08-13 | $2.44M derived: sum of 4 quarters · filed 2014-08-13 | $168.70M 10-Q · filed 2013-08-08 | |||||||||||
| 2013-03-31 | $500.00K 10-Q · filed 2014-05-08 | $695.97K 10-Q · filed 2013-05-08 | $765.04K derived: sum of 2 quarters · filed 2014-05-08 | $1.64M derived: sum of 3 quarters · filed 2014-05-08 | $3.12M derived: sum of 4 quarters · filed 2014-05-08 | $167.75M 10-Q · filed 2013-05-08 | ||||||||||||
| 2012-12-31 | $265.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $1.14M derived: sum of 2 quarters · filed 2014-03-27 | $2.62M derived: sum of 3 quarters · filed 2014-03-27 | $4.50M 10-K · filed 2014-03-27 | $5.01M 10-K · filed 2013-03-28 | $167.05M 10-K · filed 2013-03-28 | ||||||||||||
| 2012-09-30 | $872.55K 10-Q · filed 2013-11-07 | $2.36M derived: sum of 2 quarters · filed 2013-11-07 | $4.23M 10-Q · filed 2013-11-07 | $5.68M derived: sum of 4 quarters · filed 2013-11-07 | $166.28M 10-Q · filed 2012-11-08 | |||||||||||||
| 2012-06-30 | $1.48M 10-Q · filed 2013-08-08 | $3.36M 10-Q · filed 2013-08-08 | $4.80M derived: sum of 3 quarters · filed 2013-08-08 | $6.48M derived: sum of 4 quarters · filed 2013-08-08 | $165.40M 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $1.88M 10-Q · filed 2013-05-08 | $3.32M derived: sum of 2 quarters · filed 2013-05-08 | $5.00M derived: sum of 3 quarters · filed 2013-05-08 | $7.04M derived: sum of 4 quarters · filed 2013-05-08 | $163.92M 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $3.12M derived: sum of 2 quarters · filed 2013-03-28 | $5.16M derived: sum of 3 quarters · filed 2013-03-28 | $7.78M 10-K · filed 2013-03-28 | $162.04M 10-K · filed 2012-03-29 | |||||||||||||
| 2011-09-30 | $1.68M 10-Q · filed 2012-11-08 | $3.72M derived: sum of 2 quarters · filed 2012-11-08 | $6.34M 10-Q · filed 2012-11-08 | $8.62M derived: sum of 4 quarters · filed 2012-11-08 | $160.60M 10-Q · filed 2011-11-14 | |||||||||||||
| 2011-06-30 | $2.04M 10-Q · filed 2012-08-09 | $4.66M 10-Q · filed 2012-08-09 | $6.94M derived: sum of 3 quarters · filed 2012-08-09 | $9.12M derived: sum of 4 quarters · filed 2012-08-09 | $158.92M 10-Q · filed 2011-08-15 | |||||||||||||
| 2011-03-31 | $2.62M 10-Q · filed 2012-05-10 | $4.90M derived: sum of 2 quarters · filed 2012-05-10 | $7.08M derived: sum of 3 quarters · filed 2012-05-10 | $9.39M derived: sum of 4 quarters · filed 2012-05-10 | ||||||||||||||
| 2010-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $4.46M derived: sum of 2 quarters · filed 2012-03-29 | $6.76M derived: sum of 3 quarters · filed 2012-03-29 | $9.71M 10-K · filed 2012-03-29 | ||||||||||||||
| 2010-09-30 | $2.18M 10-Q · filed 2011-11-14 | $4.48M derived: sum of 2 quarters · filed 2011-11-14 | $7.43M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | $2.30M 10-Q · filed 2011-08-15 | $5.25M 10-Q · filed 2011-08-15 | ||||||||||||||||
| 2009-12-31 | $10.87M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |